QBIO
Q BioMed Inc

120
Mkt Cap
$14,509.00
Volume
6,100.00
52W High
$0.025
52W Low
$0.00
Prev Close
$0.0001
QBIO Fundamentals
50D MA
$0.0001
Beta
-8.32
Avg. Volume
32,779.63
Loading...
Loading...
Q BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring and in-licensing pre-clinical, clinical-stage and approved life sciences therapeutic products. Its products include Strontium-89, MetastronTM, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on November 22, 2013 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Q BioMed Inc?
What is the 52-week high for Q BioMed Inc?
What is the 52-week low for Q BioMed Inc?
What was Q BioMed Inc stock price yesterday?
What is the 50-day moving average of Q BioMed Inc?

Latest QBIO News

View
No QBIO news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.